Therachon's Series A - II Round

Therachon raised a round of funding on January 05, 2017.

Therachon is a global biotechnology company focused on developing treatments for rare, genetic diseases that currently have no available treatments. The company's lead pipeline candidate, TA-46, is a …

Articles about Therachon's Series A - II Round: